137 related articles for article (PubMed ID: 7584704)
1. Comparison of transdermal and oral estrogen therapy in girls with Turner's syndrome.
Jospe N; Orlowski CC; Furlanetto RW
J Pediatr Endocrinol Metab; 1995; 8(2):111-6. PubMed ID: 7584704
[TBL] [Abstract][Full Text] [Related]
2. Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome.
Mauras N; Rogol AD; Veldhuis JD
J Clin Endocrinol Metab; 1989 Nov; 69(5):1053-8. PubMed ID: 2507569
[TBL] [Abstract][Full Text] [Related]
3. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
Weissberger AJ; Ho KK; Lazarus L
J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
[TBL] [Abstract][Full Text] [Related]
4. The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome.
Ross JL; Cassorla F; Carpenter G; Long LM; Royster MS; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1988 Sep; 67(3):515-8. PubMed ID: 3410937
[TBL] [Abstract][Full Text] [Related]
5. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
Goebelsmann U; Mashchak CA; Mishell DR
Am J Obstet Gynecol; 1985 Apr; 151(7):868-77. PubMed ID: 3920910
[TBL] [Abstract][Full Text] [Related]
6. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
[TBL] [Abstract][Full Text] [Related]
7. Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism.
Ho KK; Weissberger AJ
J Bone Miner Res; 1992 Jul; 7(7):821-7. PubMed ID: 1642149
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Turner's syndrome with estrogen.
Levine LS
Pediatrics; 1978 Dec; 62(6 Pt 2):1178-83. PubMed ID: 724356
[No Abstract] [Full Text] [Related]
9. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure.
Steingold KA; Matt DW; DeZiegler D; Sealey JE; Fratkin M; Reznikov S
J Clin Endocrinol Metab; 1991 Aug; 73(2):275-80. PubMed ID: 1906893
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone plus childhood low-dose estrogen in Turner's syndrome.
Ross JL; Quigley CA; Cao D; Feuillan P; Kowal K; Chipman JJ; Cutler GB
N Engl J Med; 2011 Mar; 364(13):1230-42. PubMed ID: 21449786
[TBL] [Abstract][Full Text] [Related]
11. Biologic effects of transdermal estradiol.
Chetkowski RJ; Meldrum DR; Steingold KA; Randle D; Lu JK; Eggena P; Hershman JM; Alkjaersig NK; Fletcher AP; Judd HL
N Engl J Med; 1986 Jun; 314(25):1615-20. PubMed ID: 3012339
[TBL] [Abstract][Full Text] [Related]
12. Lp(a) and lipids in adult Turner's syndrome: impact of treatment with 17beta-estradiol and norethisterone.
Gravholt CH; Christian Klausen I; Weeke J; Sandahl Christiansen J
Atherosclerosis; 2000 May; 150(1):201-8. PubMed ID: 10781652
[TBL] [Abstract][Full Text] [Related]
13. Influence of spontaneous or induced puberty on the growth promoting effect of treatment with growth hormone in girls with Turner's syndrome.
Massa G; Maes M; Heinrichs C; Vandeweghe M; Craen M; Vanderschueren-Lodeweyckx M
Clin Endocrinol (Oxf); 1993 Mar; 38(3):253-60. PubMed ID: 8458097
[TBL] [Abstract][Full Text] [Related]
14. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.
Massa G; Bouillon R; Vanderschueren-Lodeweyckx M
J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092
[TBL] [Abstract][Full Text] [Related]
15. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome.
Mauras N; Shulman D; Hsiang HY; Balagopal P; Welch S
J Clin Endocrinol Metab; 2007 Nov; 92(11):4154-60. PubMed ID: 17711924
[TBL] [Abstract][Full Text] [Related]
17. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of oral and transdermal 17β estradiol in girls with Turner syndrome.
Taboada M; Santen R; Lima J; Hossain J; Singh R; Klein KO; Mauras N
J Clin Endocrinol Metab; 2011 Nov; 96(11):3502-10. PubMed ID: 21880799
[TBL] [Abstract][Full Text] [Related]
19. Estrogen therapy in Turner's syndrome.
Cutler GB; Ross JL
Acta Paediatr Jpn; 1992 Apr; 34(2):195-202; discussion 202-5. PubMed ID: 1621525
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of girls with Turner's syndrome with growth hormone and estrogen--1-year experiences].
Naeraa RW; Nielsen J; Kastrup KW
Ugeskr Laeger; 1992 Jun; 154(25):1773-8. PubMed ID: 1632017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
